Chickenpox clinical trials

Explore recruiting chickenpox clinical trials.

Recruiting chickenpox studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Chickenpox trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A clinical phase IV trial to examine cellular and humoral immunity against measles and chickenpox in children and adolescents 0-18 years in childhood cancer.

Sweden

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 3a, observer-blind, randomized, controlled study to evaluate the safety of an investigational varicella vaccine compared with Varivax, administered as a first dose to healthy children 12 to 15 months of age.

Lithuania, Poland, Bulgaria, Estonia, Denmark

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3a, observer-blind, randomized, controlled study to demonstrate lot-to-lot consistency and evaluate the immunogenicity and safety of an investigational varicella vaccine compared with Varivax, administered as a first dose to healthy children 12 to 15 months of age.

Czechia, Poland, Estonia, Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase II, single-blind, randomized, controlled study to evaluate the immunogenicity and safety of a measles, mumps, rubella, varicella vaccine compared with ProQuad, administered in healthy children 4 to 6 years of age

Latvia, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3a, open-label, randomized, controlled study to evaluate the immunogenicity and safety of intramuscular administration of an investigational varicella vaccine and Priorix compared with subcutaneous administration of Varivax and Priorix, when given as a first dose to healthy children 12 to 15 months of age

Denmark, Poland, Lithuania, Greece, Bulgaria, Romania +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3a, Observer-blind, Randomized, Controlled, Study to Evaluate the Immunogenicity and Safety of an Investigational Varicella Vaccine Compared with Varivax, When Given as a Second Dose to Healthy Children, 3 Months after the Administration of a First Dose at 12 to 15 Months of age

Denmark, Norway

Therapeutic confirmatory (Phase III) EU CTIS Study details

Chickenpox trials by city

Chickenpox in Toronto Chickenpox in Vancouver Chickenpox in Montreal Chickenpox in Calgary Chickenpox in Edmonton Chickenpox in Ottawa Chickenpox in Winnipeg Chickenpox in Quebec City Chickenpox in Hamilton Chickenpox in Kitchener Chickenpox in London Chickenpox in Halifax Chickenpox in New York Chickenpox in Los Angeles Chickenpox in Chicago Chickenpox in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease